Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia

Journal of Lipid Research

Volumn 43, Issue 8, 2002, Pages 1236-1243

  Oka, Tomoichiro ^a   Yamashita, Shizuya ^b   Kujiraoka, Takeshi ^a   Ito, Mayumi ^a   Nagano, Makoto ^a   Sagehashi, Yukiko ^a   Egashira, Tohru ^a   Nazeem Nanjee, M ^c   Hirano, Ken Ichi ^b   Miller, Norman E ^c   Matsuzawa, Yuji ^b   Hattori, Hiroaki ^a  

^a BioMedical Laboratory Inc ^*  (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apolipoprotein A 1 deficiency; Cholesteryl ester transfer protein deficiency; Familial high density lipoprotein deficiency; Lecithin:cholesterol acyltransferase deficiency; Phospholipid transfer protein; Tangier disease

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYPERLIPOPROTEINEMIA; HYPOLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 0036689491     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.m100349-jlr200     Document Type: Article

References (47)

1. The Tromso heart study. High-density lipoprotein and coronary heart disease: A prospective case-control study
2. High-density lipoprotein: The clinical implications of recent studies
3. Remodelling of high-density lipoproteins by plasma factors
4. Reverse cholesterol transporta review of the process and its clinical implications
5. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein
6. Unique epitope of apolipoprotein A-1 expressed in pre-β-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol
7. Lipid transfer proteins, HDL metabolism, and atherogenesis
8. The impact of phospholipid transfer protein (PLTP) on HDL metabolism
9. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio
10. Increased preβ-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes
11. Plasma phospholipid transfer protein: Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL
12. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice
13. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice
14. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): Importance of PLTP in preβ-HDL generation
15. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
16. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency
17. High density lipoprotein and coronary heart disease: Insights from mutations leading to low high density lipoprotein
18. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
19. Lecithin-cholesterol acyltransferase: Role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis
20. Mutations in the ATP binding cassette (ABC1) transporter gene in Tangier disease and familial HDL deficiency (FHD)
21. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
22. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
23. ATP-binding cassette transporter AI (ABCA1) functions as a cholesterol efflux regulatory protein
24. ABCA1: The gatekeeper for eliminating excess tissue cholesterol
25. A cysteine-containing truncated apoA-I variant associated with HDL deficiency
26. A novel homozygous missense mutation in the apoA-I gene with apoA-I deficiency
27. Severe familial HDL deficiency (FHD) in French Canadian kindred: Clinical, biochemical and molecular characterization
28. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing apoA-II in classic lecithin: Cholesterol acyltransferase deficiency and fish-eye disease
29. Familial high density lipoprotein deficiency: Tangier disease
30. 107→0) exhibit enhanced fractional catabolic rate of apoA-I in Lp (AI) and apoA-II in Lp (AI with AII)
31. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I
32. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I
33. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol
34. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
35. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
36. Measurement of human phospholipid transfer protein by sandwich enzyme-linked immunosorbent assay
37. Quantitation of human plasma phospholipid transfer protein (PLTP): Relationship between PLTP mass and phospholipid transfer activity
38. Distribution of phospholipid transfer protein in human plasma: Presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive
39. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency
40. Clinical variant of Tangier disease in Japan: Mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis
41. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans: Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency
42. Point mutation (-69 G→A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
43. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
44. Low level quantification of cholesteryl ester transfer protein in plasma subfractions and cell culture media by monoclonal antibody-based immunoassay
45. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
46. Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement
47. Isolation and partial characterization of the inactive forms of human plasma phospholipid transfer protein (PLTP)